The promising interplay between sonodynamic therapy and nanomedicine

R Canaparo, F Foglietta, N Barbero, L Serpe - Advanced Drug Delivery …, 2022 - Elsevier
Sonodynamic therapy (SDT) is a non-invasive approach for cancer treatment in which
chemical compounds, named sonosensitizers, are activated by non-thermal ultrasound …

[HTML][HTML] Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3D in vitro cancer models in the drug …

EM Tosca, D Ronchi, D Facciolo, P Magni - Biomedicines, 2023 - mdpi.com
In the last decades three-dimensional (3D) in vitro cancer models have been proposed as a
bridge between bidimensional (2D) cell cultures and in vivo animal models, the gold …

[HTML][HTML] From 2D to 3D cancer cell models—the enigmas of drug delivery research

I Van Zundert, B Fortuni, S Rocha - Nanomaterials, 2020 - mdpi.com
Over the past decades, research has made impressive breakthroughs towards drug delivery
systems, resulting in a wide range of multifunctional engineered nanoparticles with …

A comprehensive review on 3D tissue models: Biofabrication technologies and preclinical applications

R Xie, V Pal, Y Yu, X Lu, M Gao, S Liang, M Huang… - Biomaterials, 2023 - Elsevier
The limitations of traditional two-dimensional (2D) cultures and animal testing, when it
comes to precisely foreseeing the toxicity and clinical effectiveness of potential drug …

Monolayer (2D) or spheroids (3D) cell cultures for nanotoxicological studies? Comparison of cytotoxicity and cell internalization of nanoparticles

K Juarez-Moreno, D Chávez-García, G Hirata… - Toxicology in Vitro, 2022 - Elsevier
Abstract Two-dimensional (2D) cell culture monolayers are commonly used for toxicological
assessments of nanomaterials. Despite their facile handling, they exhibit several constraints …

Advances in 3D culture systems for therapeutic discovery and development in brain cancer

J Wanigasekara, PJ Cullen, P Bourke, B Tiwari… - Drug Discovery …, 2023 - Elsevier
Highlights•Existing models for drug discovery and development against glioblastoma
multiforme (GBM) have limitations.•We review advances in 3D systems that promise more …

Organoid technology: Current standing and future perspectives

L Shariati, Y Esmaeili, S Haghjooy Javanmard… - Stem Cells, 2021 - academic.oup.com
Organoids are powerful systems to facilitate the study of individuals' disorders and
personalized treatments. This emerging technology has improved the chance of …

[HTML][HTML] Cancer immunotherapy dosing: a pharmacokinetic/pharmacodynamic perspective

F Le Louedec, F Leenhardt, C Marin, É Chatelut… - Vaccines, 2020 - mdpi.com
Immune check-point inhibitors are drugs that are markedly different from other anticancer
drugs because of their indirect mechanisms of antitumoral action and their apparently …

[HTML][HTML] Three-Dimensional (3D) in vitro cell culture protocols to enhance glioblastoma research

J Wanigasekara, LJ Carroll, PJ Cullen, B Tiwari… - PLoS …, 2023 - journals.plos.org
Three-dimensional (3D) cell culture models can help bridge the gap between in vitro cell
cultures and in vivo responses by more accurately simulating the natural in vivo …

[HTML][HTML] Nanobiotechnological approaches for breast cancer Management: Drug delivery systems and 3D In-Vitro models

H Abolhassani, A Eskandari, AS Poor, A Zarrabi… - Coordination Chemistry …, 2024 - Elsevier
The science of nanotechnology has been proposed as a factor of main change in the field of
cancer diagnosis and treatment. The challenges in common clinical treatment of breast …